Evidence map›Paper›PMID 33321776›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Smart Dual-Functionalized Gold Nanoclusters for Spatio-Temporally Controlled Delivery of Combined Chemo- and Photodynamic Therapy.

Andrea Tabero, Oriol Planas, Thibault Gallavardin, Ingrid Nieves, Santi Nonell, Angeles Villanueva

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Evaluation of CoFeInternational journal of molecular sciences · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. A Photosensitized Singlet Oxygen (Molecules (Basel, Switzerland) · 2022
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Andrea TaberoDepartamento de Biología, Universidad Autónoma de Madrid, Darwin 2, 28049 Madrid, Spain.
Oriol PlanasInstitut Químic de Sarrià, Universitat Ramon Llull, 08017 Barcelona, Spain.
Thibault GallavardinInstitut Químic de Sarrià, Universitat Ramon Llull, 08017 Barcelona, Spain.ORCID 0000-0002-3339-2288
Ingrid NievesInstitut Químic de Sarrià, Universitat Ramon Llull, 08017 Barcelona, Spain.
Santi NonellInstitut Químic de Sarrià, Universitat Ramon Llull, 08017 Barcelona, Spain.ORCID 0000-0002-8900-5291
Angeles VillanuevaDepartamento de Biología, Universidad Autónoma de Madrid, Darwin 2, 28049 Madrid, Spain.
Institut Químic de Sarrià · ESMadrid Institute for Advanced Studies · ESUniversidad Autónoma de Madrid · ES

Funding

Comunidad de Madrid S2018/NMT-4321 NANOMAGCOST-CMMinisterio de Economía, Industria y Competitividad, Gobierno de España CTQ2016-78454-C2-1-RMinisterio de Economía, Industria y Competitividad, Gobierno de España CTQ2016-78454-C2-2-RMinisterio de Economía, Industria y Competitividad, Gobierno de España SEV-2016-0686
6 · The paper itself

Abstract

We report the preparation of gold nanoclusters (AuNCs) as a delivery vehicle for the clinically approved photodynamic and chemotherapeutic agents Protoporphyrin IX (PpIX) and doxorubicin (DOX), respectively, and their effect on tumor cells. DOX was attached to the gold nanoclusters through a singlet oxygen-cleavable linker and was therefore released after PpIX irradiation with red light, contributing, synergistically with singlet oxygen, to induce cell death. The doubly functionalized AuNCs proved more effective than a combination of individually functionalized AuNCs. Unlike free DOX, the photoactive nanosystem was non-toxic in the absence of light, which paves the way to introduce a spatiotemporal control of the anticancer therapy and could contribute to reducing the undesirable side effects of DOX.

Indexed as

chemophototherapydoxorubicingold nanoclustersphotodynamic therapyphotonanomedicineprotoporphyrin IX

Identifiers

PMID33321776
PMCPMC7763296
OpenAlexW3111536827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.